妊娠期糖耐量异常者产后12个月代谢结局
本研究为GDM2试验的计划性产后12个月随访,评估不同妊娠期糖耐量水平者的代谢特征与β细胞功能。407名受试者中,49人(12%)为未治疗糖耐量异常,53人(13%)为已治疗GDM;两组在孕期及产后12个月的胰岛素敏感性、β细胞功能、血脂异常及瘦素、脂联素方面均与糖耐量正常者存在显著差异。
要点
- 按CC标准未治疗的妊娠期糖耐量异常者产后12个月β细胞功能受损。
- 其代谢异常程度与已治疗GDM者相似,需持续预防关注。
- 产后12个月应重视糖耐量异常人群的代谢随访与2型糖尿病预防。
核心结论
- 按CC标准妊娠期未治疗糖耐量异常者产后12个月存在β细胞功能受损和显著代谢异常,与已治疗GDM者相似。
研究设计与样本
- GDM2试验的计划性产后12个月随访,纳入407名受试者,包括已治疗GDM、CC组未治疗糖耐量异常及部分糖耐量正常者。
主要发现
- 407名受试者中49人(12%)为未治疗糖耐量异常,53人(13%)为已治疗GDM。
- 孕期及产后12个月,未治疗糖耐量异常与已治疗GDM者的胰岛素敏感性、β细胞功能、血脂异常及瘦素、脂联素改变均与糖耐量正常者存在显著差异。
临床怎么用
- 对妊娠期糖耐量异常者产后12个月应持续关注β细胞功能与代谢指标,以预防日后2型糖尿病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Gestational diabetes mellitus (GDM) is associated with long-term risk for type 2 diabetes. OBJECTIVE: We evaluated metabolic characteristics and β-cell function during pregnancy and at 12 months postpartum among individuals with varying levels of gestational glucose intolerance. METHODS: This was a planned 12-month postpartum follow-up to the Gestational Diabetes Diagnostic Methods (GDM2) trial, which randomized pregnant individuals to GDM testing using either the International Association of Diabetes and Pregnancy Study Group (IADPSG) or Carpenter-Coustan (CC) criteria. All GDM2 participants with treated GDM (diagnosed by either CC or IADPSG), those with untreated glucose intolerance in the CC arm, and half of the participants with normal glucose tolerance were invited for 12-month follow-up. Glucose values, Stumvoll and Matsuda Indices to evaluate insulin sensitivity and resistance, the disposition index (DI), lipids, leptin, and adiponectin were assessed at 12 months postpartum. . RESULTS: Of the 407 individuals seen at 12 months, 49 (12%) had untreated glucose intolerance and 53 (13%) had treated GDM (CC and IADPSG). Both during pregnancy and at 12 months postpartum, there were significant differences in insulin sensitivity, β-cell function, dyslipidemia, and alterations in leptin and adiponectin among individuals with both untreated glucose tolerance and treated GDM when compared with those with normal glucose testing. CONCLUSION: Individuals with untreated glucose intolerance in pregnancy by the CC criteria have impaired β-cell function and significant metabolic abnormalities at 12 months postpartum similar to individuals with treated GDM, highlighting the need for ongoing preventive attention in this population to prevent type 2 diabetes later in life.
引用
- Scifres CM, Sinha A, Orris S, et al. Metabolic outcomes at 12 months postpartum among individuals with glucose intolerance in pregnancy. J Clin Endocrinol Metab. 2026. PMID: 41628201. doi:10.1210/clinem/dgag035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。